Kiniksa Pharma Signs Deal
Kiniksa Pharmaceuticals enters material definitive agreement, files 8-K with SEC. Financial statements and exhibits included.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.